Tag: foundry row
-

Council Caps Foundry Row Building Heights at 12 Stories
The city council voted 5-2 to cap new Foundry Row towers at 12 stories, with an exception allowing taller buildings near the transit corridor in exchange for more affordable units, a compromise that left both developers and tenant advocates only partly satisfied.
-

Kestrel Biologics Hits First Clinical Trial Milestone for Lead Therapy
Kestrel Biologics says its lead gene-therapy candidate has cleared an early safety milestone in its Phase 1 trial, a result executives call validation for the Foundry Row biotech firm’s $64 million funding round.
-

Kestrel Biologics Says It Has Nearly Doubled Its Bellwater Workforce
Kestrel Biologics says it has nearly doubled its Bellwater workforce, hitting its two-year hiring target partly by absorbing technicians laid off by rival Ridgeline Therapeutics.
-

Kestrel Biologics Scouts Sites for Planned Second Facility
Kestrel Biologics is scouting sites for a second manufacturing facility, including in West Bellwater, as the Foundry Row biotech firm outgrows its current lab and production space.
-

Millrace Breaks Ground on Foundry District Lofts Phase Two Despite Lawsuit
Millrace Development Partners broke ground on a 74-unit second phase of the Foundry District Lofts while a lawsuit over the first phase’s affordable-unit shortfall remains unresolved in court.
-

Lab Technicians at Kestrel Biologics Explore Union Organizing
A group of Kestrel Biologics lab technicians has quietly begun organizing around scheduling and safety-staffing concerns, a potential first test of union interest in Bellwater’s fast-growing biotech sector.
-

Ridgeline Therapeutics Cuts Staff After Clinical Trial Setback
Ridgeline Therapeutics is cutting 45 jobs after its lead drug candidate failed a mid-stage clinical trial, a setback that tempers Foundry Row’s steady biotech growth narrative.
-

Lowertown Tenants Sue Foundry Row Developer Over Affordable-Unit Shortfall
Lowertown tenants and a housing nonprofit are suing the developer behind the Foundry District Lofts, claiming it built far fewer income-restricted units than the city’s redevelopment agreement required.
-

Lab Space Crunch Threatens to Slow Foundry Row’s Biotech Growth
Wet-lab vacancy in Foundry Row has fallen below 4 percent, a shortage that biotech executives say is already complicating expansion plans and pushing some companies to consider sites outside Bellwater.
-

Forge Bellwater Welcomes Its Largest Startup Cohort Yet
Forge Bellwater has admitted 14 companies to its Foundry Row incubator, its largest cohort yet, spanning biotech, green-energy hardware and the incubator’s first AI-focused startup.